We are preparing the requested document. Please wait, this may take a while...!
|Antigen||Nerve Growth Factor beta (NGFB) Antibodies|
|Conjugate||This NGFB antibody is un-conjugated Alternatives|
Enzyme Immunoassay (EIA), Functional Studies (Func), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
|1 reference available|
|Supplier||Log in to see|
Product Details anti-NGFB AntibodyTarget Details NGFB Application Details Handling References for anti-NGFB antibody (ABIN116191) Images
|Specificity||Specific for Human beta NGF (Nerve Growth Factor). Other species not tested.|
|Purification||Affinity Chromatography employing immobilized Human beta-NGF matrix|
|Immunogen||Highly pure (>98%) E.coli derived recombinant Human beta-NGF.|
Target Details NGFBProduct Details anti-NGFB Antibody Application Details Handling References for anti-NGFB antibody (ABIN116191) Images back to top
|Alternative Name||NGF (NGFB Antibody Abstract)|
|Background||Nerve growth factor (NGF) is one of a family of neurotrophins that induce the survival and proliferation of neurons. In cell culture, NGF induces the formation of neurite projections and, in vivo, may stimulate the innervation of tissues. NGF plays a role in the repair, regeneration, and protection of neurons, and as such could serve as a therapeutic agent in neurodegenerative conditions such as Alzheimer's disease. NGF enhances survival, growth, neurotransmitter biosynthesis of sympathetic and sensory neurons, neurotrophic factor, cutaneous innervation, growth, differentiation and survival of B lymphocytes. It also has a possible role in allergy and tissue repair. NGF is found in the hypothalamus, pituitary, thyroid gland, testes, epididymis, vascular smooth muscle cells, fibroblasts, mast cells and eosinophils. NGF is upregulated by glutamate, vitamin D3, IL6, FGF basic, astrocyte specific IL1, TNF alpha, PDGF and TGF beta. It is downregulated by GABAergic neuronal activity, glucocorticoids and Schwann cell-specific TGF beta.Synonyms: Beta-NGF, Beta-nerve growth factor, NGFB|
|Research Area||Neurology, Growth Factors|
|Pathways||NF-kappaB Signaling, RTK Signaling, Regulation of Cell Size|
Application DetailsProduct Details anti-NGFB Antibody Target Details NGFB Handling References for anti-NGFB antibody (ABIN116191) Images back to top
Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity ofhuman beta NGF (1 ng/mL), a concentration of 0.05 - 0.08 μg/mL of this antibody isrequired. ELISA: To detect human beta NGF by direct ELISA (using 100l/well antibody solution) aconcentration of at least 0.5g/mL of this antibody is required. This antigen affinitypurified antibody, in conjunction with compatible secondary reagents, allows the detectionof 0.2 - 0.4 ng/well of recombinant human beta NGF. Western Blot: To detect human beta NGF by Western Blot analysis this antibody can beused at a concentration of 0.1 - 0.2 μg/mL. Used in conjunction with compatible secondaryreagents the detection limit for recombinant human beta NGF is 1.5 - 3.0 ng/lane, undereither reducing or non-reducing conditions. Immunohistochemistry on frozen sections.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
|Restrictions||For Research Use only|
HandlingProduct Details anti-NGFB Antibody Target Details NGFB Application Details References for anti-NGFB antibody (ABIN116191) Images back to top
|Reconstitution||Restore in sterile water to a concentration of 0.1-1.0 mg/mL.|
|Buffer||PBS, pH 7.2|
|Handling Advice||Avoid repeated freezing and thawing.|
|Storage||4 °C/-20 °C|
|Storage Comment||Store the antibody prior to reconstitution at -20 °C. Following reconstitution the antibody can be stored at 2-8 °C for one month or at -20 °C for longer.|
References for anti-NGFB antibody (ABIN116191)Product Details anti-NGFB Antibody Target Details NGFB Application Details Handling Images back to top
Miknyoczki, Wan, Chang, Dobrzanski, Ruggeri, Dionne, Buchkovich: "The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 8, Issue 6, pp. 1924-31, 2002